Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/5679
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection In Vitro and In Vivo
Author: Faden, A.
Knoblach, S.
Cernak, I.
Fan, L.
Vink, R.
Araldi, G.
Fricke, S.
Roth, B.
Kozikowski, A.
Citation: Journal of Cerebral Blood Flow and Metabolism, 2003; 23(3):342-354
Publisher: Lippincott Williams & Wilkins
Issue Date: 2003
ISSN: 0271-678X
1559-7016
Statement of
Responsibility: 
Alan I Faden, Susan M Knoblach, Ibolja Cernak, Lei Fan, Robert Vink, Gian Luca Araldi, Stanley T Fricke, Bryan L Roth and Alan P Kozikowski
Abstract: The authors developed a novel diketopiperazine that shows neuroprotective activity in a variety of in vitro models, as well as in a clinically relevant experimental model of traumatic brain injury (TBI) in rats. Treatment with 1-ARA-35b (35b), a cyclized dipeptide derived from a modified thyrotropin-releasing hormone (TRH) analog, significantly reduced cell death associated with necrosis (maitotoxin), apoptosis (staurosporine), or mechanical injury in neuronal–glial cocultures. Rats subjected to lateral fluid percussion–induced TBI and then treated with 1 mg/kg intravenous 35b thirty minutes after trauma showed significantly improved motor recovery and spatial learning compared with vehicle-treated controls. Treatment also significantly reduced lesion volumes as shown by magnetic resonance imaging, and decreased the number of TUNEL-positive neurons observed in ipsilateral hippocampus. Unlike TRH or traditional TRH analogs, 35b treatment did not change mean arterial pressure, body temperature, or thyroid-stimulating hormone release, and did not have analeptic activity. Moreover, in contrast to TRH or typical TRH analogs, 35b administration after TBI did not alter free-magnesium concentration or cellular bioenergetic state. Receptor-binding studies showed that 35b did not act with high affinity at 50 classical receptors, channels, or transporters. Thus, 35b shows none of the typical physiologic actions associated with TRH, but possesses neuroprotective actions in vivo and in vitro, and appears to attenuate both necrotic and apoptotic cell death.
Keywords: TRH analogs; Neuroprotection; Traumatic brain injury; Necrosis; Apoptosis.
Rights: Copyright © 2003 Nature Publishing Group
RMID: 0020031540
DOI: 10.1097/01.WCB.0000046143.31247.FD
Published version: http://www.nature.com/jcbfm/journal/v23/n3/abs/9591380a.html
Appears in Collections:Pathology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.